Seroprevalence and Associated Factors of Hepatitis B and Hepatitis C Viral Infections Among Prisoners in Tigrai, Northern Ethiopia

References

• Hutin YJF, Bulterys M, Hirnschall GO. How far are we from viral hepatitis elimination service coverage targets? J Intel AIDS Soc. 2018;21:25050.
   PubMed Web of Science ®Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of the worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555. doi:10.1016/S0140-6736(15)61412-X
   PubMed Web of Science ®Google Scholar
• World Health Organization. Department of communicable diseases surveillance and response. Hepatitis B, 2002. Available from: http://www.who.int/csr/disease/hepatitis.
   Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Robaeys G, Arain A, Stover H. Hepatitis C viral infection in prisons. In: Emerging Issues in Prison Health. Dordrecht: Springer; 2017:169–181.
   Google Scholar
• Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003;117(1):43–48. doi:10.1016/S0033-3506(02)00009-4
   PubMed Web of Science ®Google Scholar
• Wilcox RD. Hepatocellular carcinoma and HIV: is there an association? HIV Clin. 2009;21(4):11–12.
   PubMedGoogle Scholar
• Kassaian N, Adibi P, Kafashaian A, et al. Hepatitis C virus and associated risk factors among prison inmates with a history of drug injection in Isfahan, Iran. Int J Prev Med. 2012;3(l1):156.
   Google Scholar
• World Health Organization. Hepatitis: Improving the Health of Patients with Viral Hepatitis. One Hundred Thirty-Fourth Session of the Executive Board. Geneva: World Health Organization; 2014:20–24.
   Google Scholar
• Drazilova S, Kristian P, Janick M, et al. What is the role of the horizontal transmission of hepatitis B virus infection in young adult and middle-aged Roma population living in the settlements in East Slovakia? Int J Environ Res Public Health. 2020;17:3293. doi:10.3390/ijerph17093293
   PubMed Web of Science ®Google Scholar
• Berhe H, Yismaw G, Addis Z, Haileslassie H, Anagaw B, Unakal C. Seroprevalence and associated risk factors of human immunodeficiency virus and hepatitis B virus infections among prison inmates. J Pharm Biomed Sci. 2013;30(23):1035–1045.
   Google Scholar
• Kebede W, Abdissa A, Seid Y, Mekonnen Z. Seroprevalence and risk factors of hepatitis B, hepatitis C, and HIV infections among prisoners in Jimma Town, Southwest Ethiopia. Asian Pac J Trop Dis. 2017;7(5):270–275. doi:10.12980/apjtd.7.2017D6-422
   Google Scholar
• Joseph AB. Infection control in jails and prisons. Clin Infect Dis. 2007;45(8):1047–1055. doi:10.1086/521910
   PubMed Web of Science ®Google Scholar
• Massoglia M. Incarceration as exposure: the prison, infectious disease, and other stress- related illnesses. J Health Soc Behav. 2008;49:56–71. doi:10.1177/002214650804900105
   PubMed Web of Science ®Google Scholar
• Busi S, Oltaye Z. Assessment of the magnitude of sexually transmitted infections, and sexual reproductive health status among prisoners aged between 18–49 years in tabor prison, Hawassa, Ethiopia. Momona Ethiop J Sci. 2016;8(1):89–97. doi:10.4314/mejs.v8i1.8
   Google Scholar
• European Monitoring center for Drug and Drug Addiction. HIV in prison: situation and needs assessment tool kit. Vienna, United Nations Office on Drug and Crime; 2010. Available from: http://www.unodc.org/documents/hivaids/publication/HIVinprisonsituationandneedassessmentdocument.pdf. Accessed May 15, 2013.
   Google Scholar
• MacLauchlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5:a02141.
   Web of Science ®Google Scholar
• Degefa B, Gebreeyesus T, Gebremedhin Z. Prevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: a three‐year retrospective study. J Med Virol. 2018;90:1724‐1729. doi:10.1002/jmv.25248
   PubMed Web of Science ®Google Scholar
• Mezgebo TA, Niguse S, Kahsay AG, et al. Hepatitis B virus infection and associated risk factors among pregnant women attending antenatal care in health facilities of Tigray, Northern Ethiopia. J Med Virol. 2017;89:1–7. doi:10.1002/jmv.24696
   PubMedGoogle Scholar
• Salari N, Darvishi N, Hemmati M, et al. Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis. Arch Virol. 2022;167:1025–1039. doi:10.1007/s00705-022-05382-1
   PubMed Web of Science ®Google Scholar
• Kassa Y, Million Y, Biset S, Moges F. Hepatitis B and hepatitis C viral infections and associated factors among prisoners in Northeastern Ethiopia. J Blood Med. 2021;12:561–570. doi:10.2147/JBM.S314556
   PubMed Web of Science ®Google Scholar
• Woldegiorgis AE, Erku W, Medhin G, Berhe N, Legesse M. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia. PLoS One. 2019;14(12):e0226890. doi:10.1371/journal.pone.022689
   PubMed Web of Science ®Google Scholar
• Todd CS, Abed AM, Strathdee SA, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007;13(9):1327. doi:10.3201/eid1309.070036
   PubMed Web of Science ®Google Scholar
• Ziglam H, Zorgani AA, Balouz A, Abudher AH, Elahmer O. Prevalence of antibodies to human immunodeficiency virus, hepatitis B, and hepatitis C in prisoners in Libya. Libyan J Med. 2012;7. doi:10.3402/ljm.v7i0.19713
   PubMed Web of Science ®Google Scholar
• Adjei AA, Armah HB, Gbagbo F, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol. 2006;55(5):593–597. doi:10.1099/jmm.0.46414-0
   PubMed Web of Science ®Google Scholar
• Nyirenda M, Beadsworth MB, Stephany P, et al. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in medical inpatients in Malawi. J Infect. 2008;57(1):72–77. doi:10.1016/j.jinf.2008.05.004
   PubMed Web of Science ®Google Scholar
• Mohamed HI, Saad ZM, Abd-Elreheem EM, et al. Hepatitis C, hepatitis B, and HIV infection among Egyptian prisoners: seroprevalence, risk factors, and related chronic liver diseases. J Infect Public Health. 2013;6(3):186–195. doi:10.1016/j.jiph.2012.12.003
   PubMed Web of Science ®Google Scholar
• Burek V, Horvat J, Butorac K, Mikulić R. Viral hepatitis B, C, and HIV infection in Croatian prisons. Epidemol Infect. 2010;138(11):1610–1620. doi:10.1017/S0950268810000476
   Google Scholar
• Gahrton C, Westman G, Lindahl K, et al. Prevalence of Viremic hepatitis C, hepatitis B, HIV infection and vaccination status among prisoners in Stockholm County. BMC Infect Dis. 2019;19(1):955. doi:10.1186/s12879-019-4581-3
   PubMed Web of Science ®Google Scholar
• Getaz L, Casillas A, Siegrist CA, et al. Hepatitis B prevalence, risk factors, infection awareness, and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison. J Global Health. 2018;8(2):020407. doi:10.7189/jogh.08.020407
   PubMed Web of Science ®Google Scholar
• Kose S, Adar P, Gozaydin A, Kuzucu L, Akkoclu G. Hepatitis B, and Hepatitis C in prisons: a prevalence study. Int J Prison Health. 2019. doi:10.1108/IJPH-01-2018-0004
   PubMed Web of Science ®Google Scholar
• Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries. 2010;4(03):144–149. doi:10.3855/jidc.517
   PubMedGoogle Scholar
• Moradi G, Gouya MM, Azimizan Zavareh F, et al. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio-behavioral surveillance survey in 2015. Trop Med Int Health. 2018;23(6):641–649. doi:10.1111/tmi.13065
   PubMed Web of Science ®Google Scholar
• Azbel L, Polonsky M, Wegman M, et al. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be-released prisoners in Kyrgyzstan: implications for prevention and treatment Int. J Drug Policy. 2016;37:9–20. doi:10.1016/j.drugpo.2016.06.007
   PubMed Web of Science ®Google Scholar
• Dan-Nwafor C, Adeoye I, Aderemi K, et al. Knowledge, serological markers and risk factors associated with hepatitis B and C Virus infection among kuje prison inmates, federal capital territory, Nigeria. Int J Infect Dis. 2018;73:374. doi:10.1016/j.ijid.2018.04.4260
   Web of Science ®Google Scholar
• Tessema B, Yismaw G, Kassu A, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over five years. BMC Infect Dis. 2010;10:111. doi:10.1186/1471-2334-10-111
   PubMed Web of Science ®Google Scholar
• Awole M, Gebre-Selassie S. Seroprevalence of HBsAg and its risk factors among pregnant women in Jimma, Southwest Ethiopia. Ethiop J Health Dev. 2005;19(1):45–50. doi:10.4314/ejhd.v19i1.9970
   Google Scholar
• Weldemhret L, Asmelash T, Belodu R, Gebreegziabiher D. Seroprevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Ethiopia. AIDS Res Ther BioMed Centr. 2016;13:6. doi:10.1186/s12981-016-0090-2
   PubMed Web of Science ®Google Scholar
• Moges F, Kebede Y, Kassu A, et al. Seroprevalence of HIV, hepatitis B infections and syphilis among street dwellers in Gondar city, Northwest Ethiopia. Ethiop J Health Dev. 2006;20:160–165.
   Google Scholar
• Roy E, Haley N, Lemire N, Boivin JF, Leclerc P, Vincelette J. Hepatitis B virus infection among street youths in Montreal. Can Med Assoc J. 1999;161:689.
   Web of Science ®Google Scholar
• Van Dooren K, Kinner SA, Forsyth S. Risk of death for young ex‐prisoners in the year following release from adult prison. Aust N Z J. 2013;4:377–382.
   Google Scholar
• World Health Organization. WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment, and Care for Key Populations. Geneva: World Health Organization; 2014.
   Google Scholar
• McCall-Smith K. United Nations’ standard minimum rules for the treatment of prisoners (Nelson Mandela rules). Int Leg Mat. 2016;55(6):1546–1555. doi:10.1017/S0020782900030898
   Google Scholar
• Kinner SA, Jenkinson R, Gouillou M, Milloy MJ. High-risk drug-use practices among a large sample of Australian prisoners. Int J Drug Pol. 2012;126(1–2):156–160.
   Google Scholar
• Australian Institute of Health and Welfare. AIHW Canberra. The Health of Australia’s Prisoners. National Criminal Justice Reference Service NCJRS; 2015.
   Google Scholar
• Csete J, Kamarulzaman A, Kazatchkine M, et al. Public health and international drug policy. Lancet. 2016;387(10026):1427–1480. doi:10.1016/S0140-6736(16)00619-X
   PubMed Web of Science ®Google Scholar
• La Torre G, Miele L, Chiaradia G, et al. Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. BMC Infect Dis. 2007;7(1):100. doi:10.1186/1471-2334-7-100
   PubMedGoogle Scholar
• World Health Organization. Good Governance for Prison Health in the 21st Century: A Policy Brief on the Organization of Prison Health. WHO Regional Office for the fund the Europe; IRIS (Institutional Repository for Information Sharing); 2013.
   Google Scholar